Furthermore, anecdotal and emerging research suggest potential benefits in conditions such as non-alcoholic fatty liver disease
Primary sources Blue Cross Blue Shield Association, BCBS system structure Medicare.gov, current GLP-1 Bridge coverage and eligibility Current US Wegovy prescribing information FDA, current Zepbound prescribing information Evidence review completed August 2, 2026
Ngoi ra chng cn gip o thi c t hp th qua da, ng th hoc thc phm bi tit ra ngoi
High Costs & Systemic Barriers Exacerbate Health Inequities Policy Reforms Are Critical to Address Structural Inequities High Costs and Systemic Barriers Exacerbate Health Inequities: The products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) are priced at roughly $1,000 per month
Both drugs are injectable antibodies that block the function of proprotein convertase subtilisin/kexin type 9, PCSK9
How Much Should I Expect to Pay for Mounjaro (Tirzepatide)